[1]王瑞瑞.唑来膦酸注射液联合金天格胶囊治疗 绝经后骨质疏松症疗效分析[J].医学信息,2018,(17):132-134.[doi:10.3969/j.issn.1006-1959.2018.17.041]
 WANG Rui-rui.Therapeutic Effect of Zoledronic Acid Injection Combined with Jintiange Capsule on Postmenopausal Osteoporosis[J].Medical Information,2018,(17):132-134.[doi:10.3969/j.issn.1006-1959.2018.17.041]
点击复制

唑来膦酸注射液联合金天格胶囊治疗 绝经后骨质疏松症疗效分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年17期
页码:
132-134
栏目:
药物与临床
出版日期:
2018-09-01

文章信息/Info

Title:
Therapeutic Effect of Zoledronic Acid Injection Combined with Jintiange Capsule on Postmenopausal Osteoporosis
文章编号:
1006-1959(2018)17-0132-03
作者:
王瑞瑞
黑龙江省佳木斯市中心医院内分泌科,黑龙江 佳木斯 154002
Author(s):
WANG Rui-rui
Department of Endocrinology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
唑来膦酸注射液金天格胶囊绝经后骨质疏松症
Keywords:
Key words:Zoledronic acid injectionJintiange capsulePostmenopausal osteoporosis
分类号:
R58
DOI:
10.3969/j.issn.1006-1959.2018.17.041
文献标志码:
A
摘要:
目的 分析唑来膦酸注射液与金天格胶囊联合治疗绝经后骨质疏松症的效果及VAS评分。方法 选取2016年6月~2018年6月本院68例绝经后骨质疏松患者的临床资料,按照数字随机法分为对照组和研究组,各34例。对照组给予唑来膦酸注射液治疗,研究组给予唑来膦酸注射液与金天格胶囊联合治疗,比较两组的实验室相关指标、骨密度及VAS评分。结果 研究组骨密度腰椎(0.92±0.15)g/cm2、股骨颈(0.85±0.17)g/cm2、股骨大转子(0.91±0.13)g/cm2、Ward's三角区(0.81±0.12)g/cm2,高于对照组(0.72±0.11)g/cm2、(0.62±0.08)g/cm2、(0.68±0.11)g/cm2、(0.61±0.08)g/cm2,差异有统计学意义(P<0.05);骨钙素(10.28±1.27)ng/ml、骨特异性碱性磷酸酶(20.12±3.06)U/L,异有统计学意义(P<0.05);VAS评分(1.66±0.12)分,低于对照组(3.88±1.06)分,差异有统计学意义(P<0.05)。结论 唑来膦酸注射液联合金天格胶囊治疗绝经后骨质疏松症的临床效果显著,有利于改善患者的骨密度和骨代谢指标,减轻疼痛。
Abstract:
Abstract:Objective To analyze the effect of zoledronic acid injection combined with Jintiange capsule on postmenopausal osteoporosis and VAS score.Methods The clinical data of 68 postmenopausal osteoporosis patients from June 2016 to June 2018 were selected and divided into control group and study group according to the numerical random method,34 cases each.The control group was treated with zoledronic acid injection.The study group was given zoledronic acid injection combined with Jintiange capsule. The laboratory-related index, bone mineral density and VAS score were compared between the two groups.Results The study group bone mineral density lumbar vertebrae(0.92±0.15)g/cm2,femoral neck(0.85±0.17)g/cm2,femur greater trochanter(0.91±0.13)g/cm2,ward's triangle(0.81±0.12)g/cm2,higher than the control group(0.72±0.11)g/cm2,(0.62±0.08)g/cm2,(0.68±0.11)g/cm2,(0.61±0.08)g/cm2,the difference was statistically significant(P<0.05);Osteocalcin (10.28±1.27)ng/ml,bone-specific alkaline phosphatase(20.12±3.06)U/L,statistically significant(P<0.05);VAS score(1.66±0.12),lower than the control group(3.88±1.06)points,the difference was statistically significant(P<0.05).Conclusion The clinical effect of zoledronic acid injection combined with Jintiange capsule in the treatment of postmenopausal osteoporosis is significant,which is beneficial to improve bone mineral density and bone metabolism and reduce pain.

参考文献/References:

[1]袁志峰,刘会文.唑来膦酸、伊班膦酸钠及阿伦膦酸钠防治绝经后骨质疏松症的疗效对比研究[J].中国骨质疏松杂志,2018,24(02):249-252,269. [2]谢铁钢.金天格胶囊联合唑来膦酸注射液对绝经后糖尿病骨质疏松患者骨密度及实验室检查指标的影响[J].中国处方药,2018,16(03):60-61. [3]彭一,董陆玲,孙志鹏.唑来膦酸注射液联合金天格胶囊治疗绝经后骨质疏松症的疗效评价[J].中国老年保健医学,2018,16(01):81-82. [4]戴加乐,孙惠萍,胡洁云,等.金天格胶囊联合唑来膦酸注射液治疗绝经后糖尿病骨质疏松临床观察[J].中华中医药学刊,2018,36(04):916-919. [5]陈思圆,冯柏淋,郭伟雄,等.六味地黄丸联合唑来膦酸治疗妇女绝经后骨质疏松的临床研究[J].现代药物与临床,2018,33(05):1140-1144. [6]潘颖,郄素会,刘国强,等.金天格胶囊联合唑来膦酸注射液治疗绝经后糖尿病骨质疏松患者的临床观察[J].中国药房,2016,27(35):4953-4956. [7]林国友,曾文静,陈泽鹏.唑来膦酸注射液治疗绝经后骨质疏松早期不良反应情况分析[J].海峡药学,2016,28(03):247-248. [8]梅治,李青,袁元杏,等.唑来膦酸治疗绝经后骨质疏松症的临床疗效分析[J].右江民族医学院学报,2015,37(03):411-412.

更新日期/Last Update: 2018-09-01